WHAT IS ZYKADIA?
ZYKADIA™ (ceritinib) is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that is caused by a defect in a gene called ALK, which is short for anaplastic lymphoma kinase.
ZYKADIA is used to treat people who have been diagnosed with ALK-positive (ALK+) NSCLC that has spread to other parts of the body (metastatic) and who have taken the medicine crizotinib, but their NSCLC worsened or they could not tolerate taking crizotinib.